Elena Cela

Dr. Elena Cela

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2018 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
Stephan LobitzStephan Lobitz
Stephan Lobitz
PTPaul Telfer
Paul Telfer
ECElena Cela
Elena Cela
BABichr Allaf
Bichr Allaf
MAMichael Angastiniotis
Michael Angastiniotis
TEthe European Reference Network in Rare Haematological Diseases with the endorsement of EuroBloodNet
the European Reference Network in Rare Haematological Diseases with the endorsement of EuroBloodNet
Summary: Sickle Cell Disease (SCD) is an increasing global health problem and presents significant challenges to European health care systems. Newborn screening (NBS) forSCDenables early initiation of preventive measures and has contributed to a reduction in childhood mortality fromSCD. Policies and methodologies forNBSvary in different countries, and this might have consequences for the quality of care and clinical outcomes forSCDacross Europe. A two‐day Pan‐European consensus conference was held in Berlin in April 2017 in order to appraise the current status ofNBSforSCDand to develop consensus‐based statements on indications and methodology forNBSforSCDin Europe. More than 50SCDexperts from 13 European countries participated in the conference. This paper aims to summarise the discussions and present consensus recommendations which can be used to support the development ofNBSprogrammes in European countries where they do not yet exist, and to review existing programmes.

8 May 2020 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
TRTeresa de Rojas
Teresa de Rojas
APAntonio Pérez‐Martínez
Antonio Pérez‐Martínez
ECElena Cela
Elena Cela
MBMarta Baragaño
Marta Baragaño
VGVictor Galán
Victor Galán
LMLuis Madero
Luis Madero

Verified
Journal Article
Open access
PDF file
YDYvonne Daniel
Yvonne Daniel
Jacques ElionJacques Elion
Jacques Elion
BABichr ALLAF
Bichr ALLAF
CBCatherine Badens
Catherine Badens
MBMarelle Bouva
Marelle Bouva
Stephan LobitzStephan Lobitz
Stephan Lobitz
The history of newborn screening (NBS) for sickle cell disease (SCD) in Europe goes back almost 40 years. However, most European countries have not established it to date. The European screening map is surprisingly heterogenous. The first countries to introduce sickle cell screening on a national scale were France and England. The French West Indies started to screen their newborns for SCD as early as 1983/84. To this day, all countries of the United Kingdom of Great Britain and Northern Ireland have added SCD as a target disease to their NBS programs. The Netherlands, Spain and Malta also have national programs. Belgium screens regionally in the Brussels and Liège regions, Ireland has been running a pilot for many years that has become quasi-official. However, the Belgian and Irish programs are not publicly funded. Italy and Germany have completed several pilot studies but are still in the preparatory phase of national NBS programs for SCD, although both countries have well-established concepts for metabolic and endocrine disorders. This article will give a brief overview of the situation in Europe and put a focus on the programs of the two pioneers of the continent, England and France.

2 November 2016 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
ECElena Cela
Elena Cela
JBJosé M. Bellón
José M. Bellón
MCMaría de la Cruz
María de la Cruz
CBCristina Belendez
Cristina Belendez
BRBerrueco Rubén
Berrueco Rubén
OPon behalf of the SEHOP-Hemoglobinopathies Study Group (Sociedad Española de Hematología y Oncología Pediátricas)
on behalf of the SEHOP-Hemoglobinopathies Study Group (Sociedad Española de Hematología y Oncología Pediátricas)

1 April 2002 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
JBJ Bartolomé
J Bartolomé
FPF Porta
F Porta
ALA Lafranchi
A Lafranchi
JRJj Rodríguez-Molina
Jj Rodríguez-Molina
ECElena Cela
Elena Cela
JGJ Gil
J Gil

26 May 2020 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
MMMARINA GARCIA MORIN
MARINA GARCIA MORIN
EBEduardo J. Bardón-Cancho
Eduardo J. Bardón-Cancho
CBCristina Belendez
Cristina Belendez
RZRosario Zamarro
Rosario Zamarro
CBCristina Béliz-Mendiola
Cristina Béliz-Mendiola
ECElena Cela
Elena Cela